Evidence map›Paper›PMID 32999636›Full record

ArticleJournal of biomolecular techniques : JBT2020

Preparing for the Unprecedented: The Association of Biomolecular Resource Facilities (ABRF) Community Coronavirus Disease 2019 (COVID-19) Pandemic Response Part 1: Efforts to Sustainably Ramp Down Core Facility Activities.

Justine Kigenyi, Sheenah M Mische, Desiree M Porter, Joshua Z Rappoport, Andrew Vinard

Abstract read
In one paragraph

Article in Journal of biomolecular techniques : JBT, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Maximizing Shared Research Resources: Next Steps.Journal of biomolecular techniques : JBT · 2022
    Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Justine KigenyiHoglund Biomedical Imaging Center, University of Kansas Medical Center, Kansas City, Kansas 66160, USA.
Sheenah M MischeDivision of Advanced Research Technologies, NYU Langone School of Medicine, New York, New York 10016, USA.
Desiree M PorterThe University of Texas at San Antonio, San Antonio, Texas 78249, USA.
Joshua Z RappoportBoston College, Chestnut Hill, Massachusetts 02467, USA; and.
Andrew VinardInstitute for Applied Life Sciences (IALS), UMass Amherst, Amherst 01003, Massachusetts, USA.

Funding

Vaccine FacilityP30CA016087 · NCI · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI Drew R Jones · 1985 to 2026
$83.1M
NCI NIH HHS P30 CA016087
6 · The paper itself

Abstract

The coronavirus disease 2019 (COVID-19) pandemic has curtailed all but the most critical laboratory research in many institutions around the world. These unplanned and unprecedented operational changes have put considerable stress on every aspect of the research enterprise, from funding agencies to research institutes, individual and core laboratories, researchers, and research administrators, with drastic changes in demands and deliverables. The Association of Biomolecular Resource Facilities Core Administrators Network Coordinating Committee initiated a forum-wide discussion followed by a global survey to gain information on how institutions and, specifically, shared resource core facilities were responding to the COVID-19 pandemic. The survey aimed to identify shared resource core facility challenges and opportunities related to operational ramp downs, shutdowns, or research "pauses" during the COVID-19 pandemic, as well as new practices and resources needed to ensure business continuity. Although a number of positive outcomes from remote work hold promise for improved core operations, the survey results revealed a surprising level of unfamiliarity with business continuity planning for cores and limited coordination within institutions. Recommendations for business continuity planning include key stakeholders working together to assess risk, prioritize work, and promote transparency across campus.

Indexed as

PandemicsAcademies and InstitutesBiomedical ResearchCOVID-19Disaster PlanningHumansLaboratoriesMolecular BiologyResearch PersonnelSARS-CoV-2Surveys and QuestionnairesTeleworkingresource core, shared resource, core facility, shared resource, continuity planning, emergency response

Identifiers

PMID32999636
PMCPMC7505401

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.